Avacta Group PLC Asset Resilience Ratio

Latest as of June 2021: 8.33%

Avacta Group PLC asset resilience ratio. Avacta Group PLC (AVCT) has an Asset Resilience Ratio of 8.33% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Avacta Group PLC liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

GBX5.02 Million
≈ $611.15 USD Cash + Short-term Investments

Total Assets

GBX60.31 Million
≈ $7.34K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Avacta Group PLC (2016–2020)

Asset resilience ratio of Avacta Group PLC from 2016 to 2020. This chart shows how Avacta Group PLC's Asset Resilience Ratio has changed over time. Read Avacta Group PLC (AVCT) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Avacta Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Avacta Group PLC (AVCT) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX5.02 Million 8.33%
Total Liquid Assets GBX5.02 Million 8.33%

Asset Resilience Insights

  • Limited Liquidity: Avacta Group PLC maintains only 8.33% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Avacta Group PLC Industry Peers by Asset Resilience Ratio

Compare Avacta Group PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hyloris Developmentsen Sa
BR:HYL
Biotechnology 1.36%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Oruka Therapeutics, Inc.
NASDAQ:ORKA
Biotechnology 53.11%
Gempharmatech Co. Ltd. A
SHG:688046
Biotechnology 23.95%
Vor Biopharma Inc
NASDAQ:VOR
Biotechnology 74.48%
Inventiva S.A
PA:IVA
Biotechnology 52.73%
Sunmax Biotechnology Co Ltd
TWO:4728
Biotechnology 10.53%
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
Biotechnology 4.98%

Avacta Group PLC Asset Resilience Ratio by Year (2016–2020)

Avacta Group PLC asset resilience ratio by year from 2016 to 2020. The table below shows the annual Asset Resilience Ratio data for Avacta Group PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 29.67% GBX20.02 Million
≈ $2.44K
GBX67.46 Million
≈ $8.21K
+16.99pp
2017-07-31 12.68% GBX4.00 Million
≈ $486.68
GBX31.55 Million
≈ $3.84K
-13.95pp
2016-07-31 26.63% GBX10.00 Million
≈ $1.22K
GBX37.55 Million
≈ $4.57K
--
pp = percentage points

About Avacta Group PLC

LSE:AVCT UK Biotechnology
Market Cap
$3.06 Million
GBX25.16 Billion GBX
Market Cap Rank
#29421 Global
#584 in UK
Share Price
GBX57.50
Change (1 day)
-2.04%
52-Week Range
GBX49.50 - GBX89.00
All Time High
GBX274.91
About

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatec… Read more